180 related articles for article (PubMed ID: 12508174)
61. HER-2/neu detection in fine-needle aspirates of breast cancer: fluorescence in situ hybridization and immunocytochemical analysis.
Beatty BG; Bryant R; Wang W; Ashikaga T; Gibson PC; Leiman G; Weaver DL
Am J Clin Pathol; 2004 Aug; 122(2):246-55. PubMed ID: 15323142
[TBL] [Abstract][Full Text] [Related]
62. Converting fluid-based cytologic specimens to histologic specimens for immunohistochemistry.
Wallace KA; Goldschmidt MH; Patel RT
Vet Clin Pathol; 2015 Jun; 44(2):303-9. PubMed ID: 25639814
[TBL] [Abstract][Full Text] [Related]
63. Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumors: a comparison of direct smears and cell block preparations.
Liu J; Farhood A
Cancer; 2004 Apr; 102(2):109-14. PubMed ID: 15098255
[TBL] [Abstract][Full Text] [Related]
64. Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: the utility of immunocytochemical panel in the differential diagnosis.
Saleh HA; El-Fakharany M; Makki H; Kadhim A; Masood S
Diagn Cytopathol; 2009 May; 37(5):324-32. PubMed ID: 19191294
[TBL] [Abstract][Full Text] [Related]
65. Effusion cytology of esophageal carcinoma.
Renshaw AA; Nappi D; Sugarbaker DJ; Swanson S
Cancer; 1997 Dec; 81(6):365-72. PubMed ID: 9438462
[TBL] [Abstract][Full Text] [Related]
66. Cell yield. ThinPrep vs. cytocentrifuge.
Papillo JL; Lapen D
Acta Cytol; 1994; 38(1):33-6. PubMed ID: 8291353
[TBL] [Abstract][Full Text] [Related]
67. Diagnostic problems in serous effusions.
Bedrossian CW
Diagn Cytopathol; 1998 Aug; 19(2):131-7. PubMed ID: 9702493
[No Abstract] [Full Text] [Related]
68. MOC31 Immunostaining in the Diagnosis of Metastatic Adenocarcinoma in Serous Fluid: Special Emphasis on Atypical Cytological Cases.
Sahu S; Sharma S; Gupta P; Dey P
Acta Cytol; 2021; 65(3):242-249. PubMed ID: 33827073
[TBL] [Abstract][Full Text] [Related]
69. Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarian clear cell carcinoma.
Kato N; Toukairin M; Asanuma I; Motoyama T
Diagn Cytopathol; 2007 Apr; 35(4):193-7. PubMed ID: 17351940
[TBL] [Abstract][Full Text] [Related]
70. Cytomorphological and immunocytochemical study of non-Hodgkin's lymphoma in pleural effusion and ascitic fluid.
Das DK; Al-Juwaiser A; George SS; Francis IM; Sathar SS; Sheikh ZA; Shaheen A; Pathan SK; Haji BE; George J; Kapila K
Cytopathology; 2007 Jun; 18(3):157-67. PubMed ID: 17488258
[TBL] [Abstract][Full Text] [Related]
71. Charcot-Leyden crystals in pleural fluids.
Naylor B; Novak PM
Acta Cytol; 1985; 29(5):781-4. PubMed ID: 2413677
[TBL] [Abstract][Full Text] [Related]
72. [Cytodiagnosis and cytomorphologic analysis of hematolymphoid malignancy in serous effusion: a study of 23 cases].
He SR; Peng WX; Sun MJ; Yang L; He L; Su XL; He Q; Liu DG
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):691-5. PubMed ID: 23302312
[TBL] [Abstract][Full Text] [Related]
73. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
[TBL] [Abstract][Full Text] [Related]
74. The cell tube block technique and an immunohistochemistry panel including Wilms tumor 1 to assist in diagnosing cavitary effusions in dogs and cats.
Marcos R; Marrinhas C; Malhão F; Canadas A; Santos M; Caniatti M
Vet Clin Pathol; 2019 Mar; 48(1):50-60. PubMed ID: 30865320
[TBL] [Abstract][Full Text] [Related]
75. Adding the p16(INK4a) marker to the traditional 3-marker (ER/Vim/CEA) panel engenders no supplemental benefit in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Han CP; Lee MY; Kok LF; Ruan A; Wu TS; Cheng YW; Tyan YS; Lin CY
Int J Gynecol Pathol; 2009 Sep; 28(5):489-96. PubMed ID: 19696622
[TBL] [Abstract][Full Text] [Related]
76. Analysis of rare high-DNA cell populations in serous effusions using continuous-motion imaging.
Tucker JH; Stark MH; Eason P; Duvall E
Anal Cell Pathol; 1991 Jul; 3(4):233-42. PubMed ID: 1883747
[TBL] [Abstract][Full Text] [Related]
77. Tissue inhibitor of metalloproteinase 2 (TIMP-2) expression in adenocarcinoma pleural effusions.
Giarnieri E; Alderisio M; Mancini R; Falasca C; Ricci A; Mariotta S; Giovagnoli MR
Oncol Rep; 2008 Feb; 19(2):483-7. PubMed ID: 18202798
[TBL] [Abstract][Full Text] [Related]
78. Cellient™ automated cell block versus traditional cell block preparation: a comparison of morphologic features and immunohistochemical staining.
Wagner DG; Russell DK; Benson JM; Schneider AE; Hoda RS; Bonfiglio TA
Diagn Cytopathol; 2011 Oct; 39(10):730-6. PubMed ID: 20949469
[TBL] [Abstract][Full Text] [Related]
79. Lectin binding properties of cells from serous effusion and peritoneal washing specimens.
Shield PW
J Clin Pathol; 1989 Nov; 42(11):1178-83. PubMed ID: 2479665
[TBL] [Abstract][Full Text] [Related]
80. Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.
Hansel DE; DeMarzo AM; Platz EA; Jadallah S; Hicks J; Epstein JI; Partin AW; Netto GJ
J Urol; 2007 May; 177(5):1736-40. PubMed ID: 17437801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
